html[data-identity='g1'] .g1-header .g1-header-wide .g1-header-layers button { display: none; } html[data-identity='g1'] .g1-header-wide .g1-header-layers a { align-self: center; } html[data-identity='g1'] .g1-header .g1-header-narrow { display: none; } html[data-identity='g1'] .g1-header-nojs { display: none; } @media (width < 721px) { html[data-identity='g1'] .g1-header .g1-header-nojs { display: flex; flex-wrap: wrap; column-gap: 20px; padding: 0 16px 8px; } html[data-identity='g1'] .g1-header-nojs ul { display: flex; gap: 20px; list-style: none; margin: 0; padding: 0; box-shadow: none; } html[data-identity='g1'] .g1-header-nojs a { display: block; padding: 6px 0; font-size: 15px; line-height: 24px; color: var(--ink2); text-decoration: none; } html[data-identity='g1'] .g1-header-nojs a[aria-current='true'] { color: var(--ink); text-decoration: underline 2px var(--ember); text-underline-offset: 6px; } }

PapersPMID:34677681

Boron Intake and decreased risk of mortality in kidney transplant recipients.

European journal of nutrition2022The record ↗

boric acid

lowersAll-cause mortality

What moved

1 findingHow to read these marks →

Decreases all-cause mortality
limited
“Patients in tertiles 2 and 3 of boron excretion had lower risk of mortality (HR: 0.59, 95% CI: 0.41 to 0.86, and HR: 0.36, 95% CI: 0.24 to 0.56, respectively) compared with patients in tertile 1 (Table 3).”
Study
cohort
Interests
Industry funded
Population
693 stable kidney transplant recipients (mean age 53), TransplantLines cohort; tertiles 2 and 3 of 24 h urinary boron excretion versus tertile 1, crude (unadjusted) hazard ratios

Study record

Design: cohort study
Species: human
Population: Stable adult kidney transplant recipients (TransplantLines Food and Nutrition Biobank and Cohort Study)
Participants: 693
Comparator: observational
Duration: 1,972 days
Endpoints measured: 126